Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
351 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Closed (3)

Medical Condition

  • Show all (182)
  • Autoimmune Disorders (3)
  • Blood Disorders (8)
  • Cancer (111)
    • Bladder Cancer (1)
    • Brain Cancer (2)
    • Breast Cancer (2)
    • Gastrointestinal (3)
    • Gynecologic Cancer (3)
    • Head and Neck Cancer (2)
    • Kidney Cancer (3)
    • Leukemia (9)
    • Liver Cancer (1)
    • Lung Cancer (14)
    • Lymphoma (8)
    • Multiple Myeloma (6)
    • Pancreatic Cancer (1)
    • Prostate Cancer (9)
    • Sarcoma (4)
    • Skin Cancer (5)
      • (-) Melanoma (1)
      • Squamous Cell Carcinoma (4)
    • Solid Tumors (7)
  • Diabetes (1)
  • Healthy Volunteers (3)
  • Heart Disease (2)
  • Infectious Disease (3)
  • Neurological Disorders (16)
  • Nutrition (1)
  • Obstetrics & Gynecology (1)
  • Pediatrics (15)
    • Cancer (12)
      • (-) Pediatric Solid Tumors (2)
  • Psychiatric Disorders (1)
  • Transplant (16)
  • Urology (1)
Displaying 1 - 3 of 3

A study for children and adolescents with advanced non central nervous system (CNS) tumors using study drug Talimogene laherparepvec

Condition: Cancer / Pediatric Solid Tumors
Investigator: Stergios Zacharoulis, MD
Status: Closed
The purpose of this study is to find out more about how the study drug called talimogene laherparepvec will be used in children/adolescents/young adults with advanced solid tumors not involving the central nervous system that are available for direct injection. This is a phase 1 study, multicenter, open-label study, that means…
Read More

Evaluating the safety and effectiveness of study drug AMG 228 in patients with Advanced Solid Tumors

Condition: Cancer / Pediatric Solid Tumors
Investigator: Yvonne Saenger, MD
Status: Closed
This study is for patients with the following cancers: advanced non-small cell lung cancer, head and neck cancer, melanoma, colon cancer, or bladder cancer. The purpose of this study is to find out more about the effects of AMG 228 in people and on their cancer. AMG 228 is an experimental drug that is being developed to…
Read More

Study of Nivolumab in Patients with Resected Stage IIB/IIC Melanoma

Condition: Skin Cancer / Melanoma
Investigator: Larisa Geskin, MD
Status: Closed
The purpose of this study is to determine how effective and safe the immune drug Nivolumab is for patients who have newly diagnosed cutaneous melanoma. Nivolumab is an anti-body, a type of human protein, that is being tested to see if it will allow the body's immune system to work against tumor cell…
Read More
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Contact RecruitMe Terms of Use Privacy Policy ©2025 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science